BioCentury | Mar 12, 2007
Finance

Too much money

...Partnership, represented more than half of the new fund's committed capital. New investors included AlpInvest, Dow Employees' Pension Plan...
BioCentury | Mar 6, 2007
Financial News

MPM Capital closes $550 million fund

...play Peplin (ASX:PEP). Investors included GE Healthcare; Itochu; the Kauffman Foundation; Scottish Widows Investment; AlpInvest; Dow Employees' Pension Plan...
BioCentury | Jul 10, 2006
Finance

Ebb & Flow

...revenues as well. The round was led by Apposite Capital. Other new investors included the Dow Employees' Pension Plan...
BioCentury | Jul 7, 2006
Financial News

Ambrx raises $52 million

...$52 million in a series C round led by Apposite Capital. New investors Glynn Ventures; Dow Employees' Pension Plan...
BioCentury | Sep 27, 2004
Finance

Ebb & Flow

BioMarin's first announcement related to Orapred, the flagship of its new pediatrics focus, wasn't a great one, as the company expects no revenue contribution from the pediatric asthma drug in the second half. Moreover, there's...
BioCentury | Sep 21, 2004
Top Story

CMEA closes $300 million fund

CMEA Ventures (San Francisco, Calif.) closed its CMEA Ventures VI fund at $300 million. The fund will invest in four high technology and life science sectors: drug development; pharmaceutical chemistry; high-performance electronics; and outsourcing services....
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...Capital Management; Adams Street Partners; Auda Ventures; Commonfund Capital; Diamond Capital Management (agent for the Dow Employees' Pension Plan...
BioCentury | Nov 3, 2003
Financial News

Sofinnova Ventures raises $220M

...Life; VenCap; and Venture Capital Management. New limited partners include ATAPCO; CalSTRS; Credit Suisse Germany; Dow Employees' Pension Plan...
Items per page:
1 - 8 of 8
BioCentury | Mar 12, 2007
Finance

Too much money

...Partnership, represented more than half of the new fund's committed capital. New investors included AlpInvest, Dow Employees' Pension Plan...
BioCentury | Mar 6, 2007
Financial News

MPM Capital closes $550 million fund

...play Peplin (ASX:PEP). Investors included GE Healthcare; Itochu; the Kauffman Foundation; Scottish Widows Investment; AlpInvest; Dow Employees' Pension Plan...
BioCentury | Jul 10, 2006
Finance

Ebb & Flow

...revenues as well. The round was led by Apposite Capital. Other new investors included the Dow Employees' Pension Plan...
BioCentury | Jul 7, 2006
Financial News

Ambrx raises $52 million

...$52 million in a series C round led by Apposite Capital. New investors Glynn Ventures; Dow Employees' Pension Plan...
BioCentury | Sep 27, 2004
Finance

Ebb & Flow

BioMarin's first announcement related to Orapred, the flagship of its new pediatrics focus, wasn't a great one, as the company expects no revenue contribution from the pediatric asthma drug in the second half. Moreover, there's...
BioCentury | Sep 21, 2004
Top Story

CMEA closes $300 million fund

CMEA Ventures (San Francisco, Calif.) closed its CMEA Ventures VI fund at $300 million. The fund will invest in four high technology and life science sectors: drug development; pharmaceutical chemistry; high-performance electronics; and outsourcing services....
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...Capital Management; Adams Street Partners; Auda Ventures; Commonfund Capital; Diamond Capital Management (agent for the Dow Employees' Pension Plan...
BioCentury | Nov 3, 2003
Financial News

Sofinnova Ventures raises $220M

...Life; VenCap; and Venture Capital Management. New limited partners include ATAPCO; CalSTRS; Credit Suisse Germany; Dow Employees' Pension Plan...
Items per page:
1 - 8 of 8